DALACIN C Phosphat sol inj 600 mg 10 amp 4 ml
7680389781283
CH-38978
J01FF01
08.01.92
1 / 3
google
Details
- Product number
- 3897802
- CPT
- -
- Packaging group
- 10 x 4
- Unit
- ml
- Composition
- clindamycinum 600 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad pH, alcohol benzylicus 36 mg, aqua ad iniectabile ad solutionem pro 4 ml corresp. natrium 35.84 mg.
Articles (1)
Dalacin C Phosphat 600 mg, Injektionslösung
Injektionslösung
10 x 4
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
36.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
35.84 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 38978
- Drug name
- Dalacin C Phosphat, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- J01FF01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/07/1975
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.92
- Domain
- Human medicine
Packaging details
- Description (FR)
- DALACIN C Phosphat sol inj 600 mg 10 amp 4 ml
- Description (DE)
- DALACIN C Phosphat Inj Lös 600 mg 10 Amp 4 ml
- Market launch
- 11/07/1975
- Narcotic (BTM)
- No